Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

Abstract Almost all individuals with Down Syndrome (DS) develop Alzheimer’s disease (AD) by mid to late life. However, the degree to which AD in DS shares pathological changes with sporadic late-onset AD (LOAD) and autosomal dominant AD (ADAD) beyond core AD biomarkers such as amyloid-β (Aβ) and tau...

Full description

Saved in:
Bibliographic Details
Main Authors: Laia Montoliu-Gaya, Shijia Bian, Eric B. Dammer, Daniel Alcolea, Mathias Sauer, Mitchell Martá-Ariza, Nicholas J. Ashton, Olivia Belbin, Johannes Fuchs, Caroline M. Watson, Lingyan Ping, Duc M. Duong, Johanna Nilsson, Isabel Barroeta, Juan Lantero-Rodriguez, Laura Videla, Bessy Benejam, Blaine R. Roberts, Kaj Blennow, Nicholas T. Seyfried, Allan I. Levey, María Carmona-Iragui, Johan Gobom, Alberto Lleó, Thomas Wisniewski, Henrik Zetterberg, Juan Fortea, Erik C. B. Johnson
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-61054-z
Tags: Add Tag
No Tags, Be the first to tag this record!